Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Postoperative Use of Dextenza (Dexamethasome Ophthalmic Insert) vs a Standard Regimen of Topical Fluorometholone After PRK

NCT05587231 is registered in ClinicalTrials.gov with Navy Medical Center San Diego as lead sponsor.

NCT NCT05587231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05587231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Postoperative Use of Dextenza (Dexamethasome Ophthalmic Insert) vs a Standard Regimen of Topical Fluorometholone After PRK
Lead sponsor
Navy Medical Center San Diego
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2022
Completion date
October 31, 2024
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

steroid ophthalmic insert